TRACON Pharmaceuticals, Inc. is a fast growing biotechnology company developing next-generation targeted therapies for cancer and related diseases. We are addressing unmet needs in this arena with product candidates that focus on cellular targets specifically implicated in cancer growth and angiogenesis. We believe that these treatments will offer benefits far exceeding those provided by cytotoxic treatments and first generation targeted therapies.

By developing and commercializing novel oncology products in underserved indications with improved results, TRACON will maximize patient benefits and enhance shareholder value.